INNOventure invests in Drukuje.to
INNOventure invests in Saventic Health solutions
INNOventure invests in an evolutionary AI system to quickly train neural networks for any computer vision application
Three of our portfolio companies have been qualified for the acceleration program
At the same time, the company is appreciated on the European forum
Microsoft, PZU Group and uPacjenta.pl as the newest partners of the company
Startups of the third and fourth rounds are getting ready
Cardiomatics develops its technology in response to the increasing demand
The researchers managed to achieve almost two years of disease remission after administration of the Treg preparation
The company's response to Covid-19
INNOventure invests in RevDeBug
New product lines and services
